01 1Zanoprima Lifesciences
01 1NICOTINE USP (SYNTHETIC)
01 1United Kingdom
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-08-24
Pay. Date : 2022-07-11
DMF Number : 37223
Submission : 2022-07-18
Status : Active
Type : II
20
Zanoprima Lifesciences Ltd, based in United Kingdom, is a pharmaceutical company.
One of their notable products is NICOTINE USP (SYNTHETIC), with a corresponding US DMF Number 37223.
Remarkably, this DMF maintains an Active status since its submission on July 18, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 24, 2022, and payment made on July 11, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
